CARBIDOPA AND LEVODOPA (CARBIDOPA; LEVODOPA) — FDA Approval ANDA210341 (ALEMBIC)
CARBIDOPA AND LEVODOPA (CARBIDOPA; LEVODOPA) — FDA Approval ANDA210341 (ALEMBIC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: CARBIDOPA AND LEVODOPA; Active ingredients: CARBIDOPA; LEVODOPA; Application number: ANDA210341.
| Brand name | CARBIDOPA AND LEVODOPA |
|---|---|
| Active ingredients | CARBIDOPA; LEVODOPA |
| Application number | ANDA210341 |
| Sponsor | ALEMBIC |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20190605 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →